English | Español
Patient Daily | Feb 5, 2026

Regulatory professionals address challenges from new FDA guidance and evolving technology
Patient Daily | Feb 5, 2026

Town of Wallkill bans vaping on public property following youth advocacy
Patient Daily | Feb 5, 2026

Merck ends talks with Revolution Medicines over acquisition price disagreement
Patient Daily | Feb 5, 2026

Sarepta reports sustained benefit from DMD gene therapy three years after treatment
Patient Daily | Feb 5, 2026

Corcept reports positive Phase III results for ovarian cancer drug relacorilant
Patient Daily | Feb 5, 2026

Sandbox approach proposed as new model for rare disease drug development
Patient Daily | Feb 5, 2026

Revolution Medicines remains independent after failed takeover talks with Merck
Patient Daily | Feb 5, 2026

Study finds tertiary treatment reduces antibiotic resistance transfer from reclaimed irrigation water

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'